NZ573439A - Amino-piperidine derivatives as cetp inhibitors - Google Patents

Amino-piperidine derivatives as cetp inhibitors

Info

Publication number
NZ573439A
NZ573439A NZ573439A NZ57343907A NZ573439A NZ 573439 A NZ573439 A NZ 573439A NZ 573439 A NZ573439 A NZ 573439A NZ 57343907 A NZ57343907 A NZ 57343907A NZ 573439 A NZ573439 A NZ 573439A
Authority
NZ
New Zealand
Prior art keywords
alkyl
amino
aryl
cycloalkyi
benzyl
Prior art date
Application number
NZ573439A
Other languages
English (en)
Inventor
Hidetomo Imase
Yuki Iwaki
Toshio Kawanami
Takahiro Miyake
Muneto Mogi
Osamu Ohmori
Hongbo Qin
Ichiro Umemura
Ken Yamada
Kayo Yasoshima
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2007/006384 external-priority patent/WO2008009435A1/en
Publication of NZ573439A publication Critical patent/NZ573439A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ573439A 2006-07-20 2007-07-18 Amino-piperidine derivatives as cetp inhibitors NZ573439A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06117541 2006-07-20
US88705807P 2007-01-29 2007-01-29
PCT/EP2007/006384 WO2008009435A1 (en) 2006-07-20 2007-07-18 Amino-piperidine derivatives as cetp inhibitors

Publications (1)

Publication Number Publication Date
NZ573439A true NZ573439A (en) 2012-02-24

Family

ID=37680601

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ573439A NZ573439A (en) 2006-07-20 2007-07-18 Amino-piperidine derivatives as cetp inhibitors

Country Status (13)

Country Link
KR (1) KR20120034774A (da)
CN (1) CN101490035B (da)
BR (1) BRPI0714516A2 (da)
DK (1) DK2049517T3 (da)
ES (1) ES2449571T3 (da)
MY (1) MY153262A (da)
NZ (1) NZ573439A (da)
PT (1) PT2049517E (da)
RU (1) RU2442782C2 (da)
SG (1) SG173378A1 (da)
SI (1) SI2049517T1 (da)
UA (1) UA96942C2 (da)
ZA (1) ZA200810008B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112898257B (zh) * 2021-03-12 2023-01-24 天津理工大学 一种水溶性香豆素衍生物内盐的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines

Also Published As

Publication number Publication date
ZA200810008B (en) 2009-11-25
ES2449571T3 (es) 2014-03-20
SG173378A1 (en) 2011-08-29
MY153262A (en) 2015-01-29
RU2009105763A (ru) 2010-08-27
KR20120034774A (ko) 2012-04-12
DK2049517T3 (da) 2014-03-03
CN101490035A (zh) 2009-07-22
PT2049517E (pt) 2014-03-10
SI2049517T1 (sl) 2014-04-30
RU2442782C2 (ru) 2012-02-20
BRPI0714516A2 (pt) 2014-07-08
CN101490035B (zh) 2013-02-13
UA96942C2 (uk) 2011-12-26

Similar Documents

Publication Publication Date Title
AU2007276433B2 (en) Amino-piperidine derivatives as CETP inhibitors
US8420641B2 (en) Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives
US8759365B2 (en) Organic compounds
US20100041705A1 (en) Organic Compounds
US20100076021A1 (en) Organic Compounds
DK2049517T3 (da) Aminopiperidinderivater som CETP-inhibitorer
AU2012202172B2 (en) 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 18 JUL 2017 BY CPA GLOBAL

Effective date: 20140605

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 18 JUL 2018 BY CPA GLOBAL

Effective date: 20170622

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 18 JUL 2019 BY CPA GLOBAL

Effective date: 20180622

LAPS Patent lapsed